Infection Epidemiology and Microbiology, Год журнала: 2024, Номер 10(4), С. 277 - 285
Опубликована: Дек. 1, 2024
Язык: Английский
Infection Epidemiology and Microbiology, Год журнала: 2024, Номер 10(4), С. 277 - 285
Опубликована: Дек. 1, 2024
Язык: Английский
Peptides, Год журнала: 2024, Номер unknown, С. 171311 - 171311
Опубликована: Окт. 1, 2024
Язык: Английский
Процитировано
1Advanced Drug Delivery Reviews, Год журнала: 2024, Номер 215, С. 115472 - 115472
Опубликована: Ноя. 15, 2024
Язык: Английский
Процитировано
1Nanomedicine Nanotechnology Biology and Medicine, Год журнала: 2024, Номер unknown, С. 102796 - 102796
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
1Biotechnology Advances, Год журнала: 2024, Номер unknown, С. 108492 - 108492
Опубликована: Дек. 1, 2024
The prevalence of multidrug-resistant (MDR) ESKAPE pathogens, including Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, and Pseudomonas aeruginosa, represents a critical global public health challenge. In response, mRNA vaccines offer an adaptable scalable platform for immunotherapy against pathogens by encoding specific antigens that stimulate B-cell-driven antibody production CD8
Язык: Английский
Процитировано
1Archives of Microbiology, Год журнала: 2024, Номер 207(1)
Опубликована: Дек. 26, 2024
Язык: Английский
Процитировано
1Microbiology Research, Год журнала: 2024, Номер 15(4), С. 2661 - 2672
Опубликована: Дек. 12, 2024
Background and Objectives: Klebsiella pneumoniae is a major nosocomial pathogen with remarkable ability to develop resistance multiple antibiotics, posing significant treatment challenges. This study aims evaluate the antimicrobial patterns among multidrug-resistant (MDR) non-MDR strains of K. isolated over six-year period (2018–2023) at Clinical Hospital Infectious Diseases Pulmonology “Dr. Victor Babes” in Timisoara, Romania. The objectives include categorizing isolates based on their antibiotic profiles identifying trends key antibiotics optimize strategies enhance infection control measures. Materials Methods: A cross-sectional analysis was conducted obtained from various clinical samples between January 2018 December 2023. Identification performed using standard bacteriological procedures, susceptibility testing Kirby–Bauer disk diffusion method accordance EUCAST guidelines. Isolates were classified as susceptible, resistant, MDR, extensively drug-resistant (XDR), or pandrug-resistant (PDR) ECDC definitions. Data analyzed GraphPad Prism 6, chi-square tests Cochran–Armitage trend applied where appropriate. Statistical significance set p < 0.05. Results: total 1,081 identified period, increasing 118 319 proportion XDR PDR showed upward 30.5% 57.4% 2023 (p 0.001). Specifically, increased 22.9% 39.8% 2023, while rose 7.6% 17.6%. Among monomicrobial infections accounted for 42.4% 16.5%, respectively. Resistance carbapenems also increase; instance, ertapenem 35.6% 54.2% Subgroup revealed that bronchial aspirates had highest rates 38.0% 17.2%, Additionally, polymicrobial both co-infecting pathogens XDR/PDR 24.2% 46.6% Conclusions: demonstrates escalation particularly strains. rising critical like underscores urgent need enhanced stewardship Targeted interventions are essential curb spread these resistant therapeutic strategies.
Язык: Английский
Процитировано
0Infection Epidemiology and Microbiology, Год журнала: 2024, Номер 10(4), С. 277 - 285
Опубликована: Дек. 1, 2024
Язык: Английский
Процитировано
0